1.5 billion people worldwide suffer from chronic pain and over half of them are not satisfied with their care. Remedee Labs aims to give these patients a new life.
Founded in 2016 in Grenoble, France, and based on 10 years of pre-clinical and clinical research, Remedee Labs has designed and developed the first endorphin stimulation solution, which is transforming chronic pain management.
Building on the experience of its clinical partners, the company now uses its unique technology to offer the first patient-centered digital service platform for chronic pain management, working alongside medical practitioners. Remedee Labs initial focus is helping patients with fibromyalgia and plans to extend the Platform offering to other chronic pain conditions in the future, such as migraine, osteo-arthritis, endometriosis or cancer pain for example.
Location: France, Auvergne-Rhône-Alpes, Meylan
Member count: 11-50
Founded date: 2016
Investors 4
| Date | Name | Website |
| 01.06.2021 | Hardware c... | hardwarecl... |
| - | C4 Venture... | c4v.com |
| - | Hardware C... | hcvc.co |
| - | Partech Pa... | partechpar... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 19.08.2023 | Startup Showcase: Remedee Labs – Pioneer in Chronic Pain All... | Chronic pain, an ailment plaguing an astounding 1.5 billion people globally, has been an age-old med... | eustartup.... |
| 07.08.2023 | European tech companies are leading the fight against debili... | Did you know that chronic pain affects more than 1.5 billion people worldwide? Chronic and regular ... | tech.eu/20... |